Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2025-12-25 @ 3:25 AM
NCT ID:
NCT07092605
Eligibility Criteria:
Inclusion Criteria:
* New or existing AgelessRx patient
* Adults (aged 18-65)
* Any sex
* Any ethnicity
* BMI ≥ 20 kg/m\^2
* Interest in taking microdoses of semaglutide for health and longevity improvement with no intent to seek weight loss improvement.
Exclusion Criteria:
* Individuals who are denied a longevity product by the AgelessRx medical team will not be asked to participate in any product specific test(s) or questionnaire(s)
* History of bariatric surgery
* Use of other weight-loss medications currently or within the past 6 months
* Contraindications to semaglutide
* Significant psychiatric illness that may affect participation
* Pregnant or breastfeeding individuals
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07092605
Study Brief:
Protocol Section:
NCT07092605